Health & Life Co., Ltd.
Health & Life Co., Ltd. manufactures and sells products for cardiovascular disease, in-vitro diagnostics, and respiratory care worldwide. It offers vibrating mesh nebulizers, blood pressure monitor products, IR thermometers, and hearing aid devices. The company was founded in 1996 and is based in New Taipei City, Taiwan.
Health & Life Co., Ltd. (1781) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.044x
Based on the latest financial reports, Health & Life Co., Ltd. (1781) has a cash flow conversion efficiency ratio of -0.044x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-14.46 Million) by net assets (NT$329.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Health & Life Co., Ltd. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Health & Life Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Health & Life Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Health & Life Co., Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dish TV India Limited
PINK:DTTVY
|
-0.042x |
|
Saga Pure ASA
OL:SAGA
|
0.004x |
|
Voyageur Pharmaceuticals Ltd
PINK:VYYRF
|
-0.694x |
|
LMS Co. Ltd
KQ:073110
|
-0.059x |
|
Delta Resources Ltd
PINK:DTARF
|
-0.513x |
|
BeLive Holdings Ordinary Share
NASDAQ:BLIV
|
N/A |
|
Medion AG
XETRA:MDN
|
-0.009x |
|
Malton Bhd
KLSE:6181
|
-0.051x |
Annual Cash Flow Conversion Efficiency for Health & Life Co., Ltd. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Health & Life Co., Ltd. from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$393.05 Million | NT$33.35 Million | 0.085x | -66.48% |
| 2023-12-31 | NT$335.37 Million | NT$84.91 Million | 0.253x | +216.90% |
| 2022-12-31 | NT$372.58 Million | NT$-80.69 Million | -0.217x | +37.55% |
| 2021-12-31 | NT$378.18 Million | NT$-131.15 Million | -0.347x | -- |